Regeneron Pharmaceuticals, Inc 10-Q for FY2022 Q2
Regeneron Pharmaceuticals, Inc. (REGN)
10-Q
2022-08-03
For: 2022-06-30
View Original
Added on
April 08, 2026
About this 10-Q
Regeneron Pharmaceuticals, Inc filed this 10-Q on August 3, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).
Headline figures
Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.86B
- down 44.4% from $5.14B a year earlier
- Net income
- $852.1M
- down 72.5% from net income of $3.1B a year earlier
- Diluted EPS
- $7.47
- down 73.3% from $27.97 a year earlier